Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chu Matsuda

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
International Journal of Oncology|December 22, 2016
Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosisKenji Kawai, Mamoru Uemura, Koji Munakata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Two Cases of Pathological Complete Response with Neoadjuvant Therapy for Advanced Rectal Cancer]Chu Matsuda, Katsuki Danno, Susumu Miyazaki, et al.
Molecular Diagnosis & Therapy|May 16, 2014
FcγR and EGFR polymorphisms as predictive markers of cetuximab efficacy in metastatic colorectal cancerYuka Inoue, Shoichi Hazama, Shigeyoshi Iwamoto, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2017
Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapyTsunekazu Mizushima, Mutsumi Fukunaga, Toshinori Sueda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Case of Unresectable Advanced Gastric Cancer Treated with Radiotherapy and Trans-Arterial Embolization, Resulting in Effective Hemostasis]Yuichiro Okumura, Junji Kawada, Kazumasa Fujitani, et al.
Anticancer Research|October 3, 2022
Combined Inflammation and Nutrition Factors Reinforce the Prognostic Prediction for Stage III Colorectal Cancer PatientsShinya Kato, Norikatsu Miyoshi, Shiki Fujino, et al.
International Journal of Colorectal Disease|August 4, 2021
Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancerKen Nakata, Takamichi Komori, Kazuhiro Saso, et al.
Annals of Gastroenterological Surgery|January 16, 2023
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancerChu Matsuda, Toshihiro Kudo, Yoshihiro Morimoto, et al.
Surgery Today|October 10, 2019
Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancerYuki Sekido, Junichi Nishimura, Shiki Fujino, et al.
Surgery Today|August 15, 2018
Benefits of using a self-expandable metallic stent as a bridge to surgery for right- and left-sided obstructive colorectal cancersShunji Morita, Kansuke Yamamoto, Atsuhiro Ogawa, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
International Journal of Oncology|December 22, 2016
Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosisKenji Kawai, Mamoru Uemura, Koji Munakata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[Two Cases of Pathological Complete Response with Neoadjuvant Therapy for Advanced Rectal Cancer]Chu Matsuda, Katsuki Danno, Susumu Miyazaki, et al.
Molecular Diagnosis & Therapy|May 16, 2014
FcγR and EGFR polymorphisms as predictive markers of cetuximab efficacy in metastatic colorectal cancerYuka Inoue, Shoichi Hazama, Shigeyoshi Iwamoto, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2017
Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapyTsunekazu Mizushima, Mutsumi Fukunaga, Toshinori Sueda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Case of Unresectable Advanced Gastric Cancer Treated with Radiotherapy and Trans-Arterial Embolization, Resulting in Effective Hemostasis]Yuichiro Okumura, Junji Kawada, Kazumasa Fujitani, et al.
Anticancer Research|October 3, 2022
Combined Inflammation and Nutrition Factors Reinforce the Prognostic Prediction for Stage III Colorectal Cancer PatientsShinya Kato, Norikatsu Miyoshi, Shiki Fujino, et al.
International Journal of Colorectal Disease|August 4, 2021
Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancerKen Nakata, Takamichi Komori, Kazuhiro Saso, et al.
Annals of Gastroenterological Surgery|January 16, 2023
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancerChu Matsuda, Toshihiro Kudo, Yoshihiro Morimoto, et al.
Surgery Today|October 10, 2019
Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancerYuki Sekido, Junichi Nishimura, Shiki Fujino, et al.
Surgery Today|August 15, 2018
Benefits of using a self-expandable metallic stent as a bridge to surgery for right- and left-sided obstructive colorectal cancersShunji Morita, Kansuke Yamamoto, Atsuhiro Ogawa, et al.
Pageof 18